Enzyme-Linked Immunosorbent Assay (ELISA) Market (Updated Version Available)

The report offers detailed coverage of Enzyme-Linked Immunosorbent Assay (ELISA) industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Enzyme-Linked Immunosorbent Assay (ELISA) by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
The global average price of ELISA is in the decreasing trend, from 211 USD /Unit in 2011 to 196 USD/ Unit in 2015. with the situation of global economy, prices will be in decreasing trend in the following five years.

the classification of ELISA includes ELISA Sets ELISA Kits, and the proportion of ELISA Kits in 2015 is about 61%.ELISA is widely used in IVD testing field.

USA is the largest supplier of ELISA, with a production market share nearly 48% in 2015. Europe is the second largest supplier of ELISA, enjoying production market share nearly 34% in 2015.

North america is the largest consumption place, with a consumption market share nearly 40% in 2015. following north america, europe is the second largest consumption place with the consumption market share of 26%. China is the world's largest import country.

market competition is not intense. R&D Systems and Thermo Fisher Scientific, are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.



The report forecast global Enzyme-Linked Immunosorbent Assay (ELISA) market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.

First, this report covers the present status and the future prospects of the global Enzyme-Linked Immunosorbent Assay (ELISA) market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Shenzhen YHLO Biotech


At the same time, we classify Enzyme-Linked Immunosorbent Assay (ELISA) according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
Market by Order Type
ELISA Sets
ELISA Kits
Market by Application
ELISA in HIV
ELISA in West Nile Virus
Detecting Antigens or Antibodies
Biodefense

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Enzyme-Linked Immunosorbent Assay (ELISA) market for the forecast period 2021 - 2025?
• What are the driving forces in the Enzyme-Linked Immunosorbent Assay (ELISA) market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Enzyme-Linked Immunosorbent Assay (ELISA) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?